Burford Brothers’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Sell |
155,323
-553
| -0.4% | -$9.27K | 1.19% | 16 |
|
|
2025
Q1 | $2.4M | Buy |
155,876
+3,189
| +2% | +$49K | 1.16% | 17 |
|
|
2024
Q4 | $3.37M | Sell |
152,687
-575
| -0.4% | -$12.7K | 1.65% | 12 |
|
|
2024
Q3 | $2.76M | Buy |
153,262
+5,618
| +4% | +$101K | 1.44% | 13 |
|
|
2024
Q2 | $2.4M | Buy |
147,644
+6,585
| +5% | +$107K | 1.39% | 14 |
|
|
2024
Q1 | $1.99M | Buy |
141,059
+1,360
| +1% | +$19.2K | 1.31% | 15 |
|
|
2023
Q4 | $1.46M | Buy |
+139,699
| New | +$1.46M | 1.03% | 23 |
|